Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
CRO
Charles River inks $510M deal to bring primate supply in-house
The service provider shared the news alongside details of a $60 million deal to buy the developer of a non-animal testing technology.
Nick Paul Taylor
Jan 14, 2026 10:45am
Pretzel emerges as winner from rise and fall of Rome
Jan 13, 2026 9:55am
Lilly buys inflammation biotech Ventyx for $1.2B
Jan 8, 2026 7:01am
Philips claims AI cardiac imaging developer SpectraWAVE
Dec 15, 2025 10:35am
Sobi pays $950M upfront to snap up gout specialist Arthrosi
Dec 15, 2025 8:15am
Teleflex inks $2B in divestment deals for 3 company units
Dec 9, 2025 12:26pm
